Equifax FY26 Results: Sales guidance cut to $6.646B-$6.676B

1 min read | Published on 20 Oct 2026, 04:10 PM |Updated on 20 Oct 2026, 04:10 PM

Reviewed by

Naman SScanX News Team

Add as a preferred
source on Google

Key Highlights

Equifax lowered FY26 sales guidance to $6.646B-$6.676B from $6.710B-$6.780B
Revised sales outlook is below the analyst estimate of $6.736B
Adjusted EPS guidance narrowed to $8.45-$8.55 from $8.39-$8.69
New EPS range straddles the $8.50 analyst estimate

*this image is generated using AI for illustrative purposes only.

Equifax Inc lowered its fiscal 2026 sales guidance to a range of $6.646 billion to $6.676 billion, marking a reduction from the previous outlook of $6.710 billion to $6.780 billion. The revised range sits below the consensus analyst estimate of $6.736 billion.

The credit reporting firm also narrowed its adjusted earnings per share (EPS) guidance for the fiscal year. The new range is set at $8.45 to $8.55, tightened from the prior forecast of $8.39 to $8.69. This updated EPS projection remains slightly below the analyst estimate of $8.50.

Guidance Revisions

The company’s updated financial outlook reflects a more conservative stance on both top-line revenue and bottom-line profitability compared to earlier projections. The narrowing of the EPS band suggests increased certainty around earnings performance, albeit at a lower midpoint than initially anticipated.

Metric	Previous Guidance	Revised Guidance	Analyst Estimate
Adjusted EPS	$8.39 - $8.69	$8.45 - $8.55	$8.50
Sales	$6.710B - $6.780B	$6.646B - $6.676B	$6.736B

What the Numbers Show

The revision indicates a divergence between the company's internal expectations and market consensus. While the upper end of the new EPS range ($8.55) exceeds the analyst estimate ($8.50), the lower bound ($8.45) falls short. More significantly, the entire revised sales range ($6.646B-$6.676B) is below the single-point analyst estimate of $6.736B, suggesting the market may have been overly optimistic regarding Equifax's revenue trajectory for the fiscal year.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific macroeconomic headwinds or sector-specific slowdowns are driving Equifax's revenue guidance cut?

How might this revenue miss impact the valuation multiples of other credit reporting peers like Experian and TransUnion?

Will the narrowed EPS range signal a shift in Equifax's capital allocation strategy, such as reduced buybacks or dividends?

Read Next Article

Mizuho keeps Outperform on Equifax, cuts price target to $185

0 min read | Published on 19 Oct 2026, 06:17 PM |Updated on 19 Oct 2026, 06:17 PM

Reviewed by

Ashish TScanX News Team

Add as a preferred
source on Google

Key Highlights

Mizuho analyst Sean Kennedy maintained an Outperform rating on Equifax
The price target was lowered from $210 to $185
The revision reflects a $25 reduction in valuation expectations

*this image is generated using AI for illustrative purposes only.

Equifax Inc saw its price target lowered to $185 by Mizuho analyst Sean Kennedy, who maintained an Outperform rating on the stock.

The adjustment represents a reduction of $25 from the previous target of $210. Despite the lower valuation ceiling, the analyst retained a positive stance on the company's outlook.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific macroeconomic factors or regulatory changes are driving Mizuho's decision to lower Equifax's price target despite maintaining an Outperform rating?

How might this valuation adjustment influence institutional investor sentiment and potential capital flows into the broader credit reporting sector?

Are there emerging competitive pressures from fintech alternatives or open banking initiatives that could impact Equifax's long-term revenue growth assumptions?